| Product Code: ETC7493748 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Hungary Artificial Intelligence (AI) in Drug Discovery Market Overview |
3.1 Hungary Country Macro Economic Indicators |
3.2 Hungary Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume, 2021 & 2031F |
3.3 Hungary Artificial Intelligence (AI) in Drug Discovery Market - Industry Life Cycle |
3.4 Hungary Artificial Intelligence (AI) in Drug Discovery Market - Porter's Five Forces |
3.5 Hungary Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.6 Hungary Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.7 Hungary Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.8 Hungary Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume Share, By Offering, 2021 & 2031F |
3.9 Hungary Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.10 Hungary Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume Share, By End Use, 2021 & 2031F |
4 Hungary Artificial Intelligence (AI) in Drug Discovery Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for innovative drug discovery solutions |
4.2.2 Growing investments in AI technologies in the healthcare sector |
4.2.3 Rising prevalence of chronic diseases driving the need for efficient drug discovery processes |
4.3 Market Restraints |
4.3.1 High initial investment required for implementing AI in drug discovery |
4.3.2 Lack of skilled professionals in AI and drug discovery domain |
4.3.3 Data privacy and security concerns in handling sensitive healthcare data |
5 Hungary Artificial Intelligence (AI) in Drug Discovery Market Trends |
6 Hungary Artificial Intelligence (AI) in Drug Discovery Market, By Types |
6.1 Hungary Artificial Intelligence (AI) in Drug Discovery Market, By Application |
6.1.1 Overview and Analysis |
6.1.2 Hungary Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume, By Application, 2021- 2031F |
6.1.3 Hungary Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume, By Novel Drug Candidates, 2021- 2031F |
6.1.4 Hungary Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume, By Drug Optimization and Repurposing Preclinical Testing and Approval, 2021- 2031F |
6.1.5 Hungary Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume, By Drug Monitoring, 2021- 2031F |
6.1.6 Hungary Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume, By Aggregating and Synthesizing Information, 2021- 2031F |
6.1.7 Hungary Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume, By Formation and Qualification of Hypotheses, 2021- 2031F |
6.1.8 Hungary Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume, By De Novo Drug Design, 2021- 2031F |
6.1.9 Hungary Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume, By Others, 2021- 2031F |
6.1.10 Hungary Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Hungary Artificial Intelligence (AI) in Drug Discovery Market, By Technology |
6.2.1 Overview and Analysis |
6.2.2 Hungary Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume, By Machine Learning, 2021- 2031F |
6.2.3 Hungary Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume, By Deep Learning, 2021- 2031F |
6.2.4 Hungary Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume, By Natural Language Processing, 2021- 2031F |
6.2.5 Hungary Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Hungary Artificial Intelligence (AI) in Drug Discovery Market, By Drug Type |
6.3.1 Overview and Analysis |
6.3.2 Hungary Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume, By Small Molecule, 2021- 2031F |
6.3.3 Hungary Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume, By Large Molecule, 2021- 2031F |
6.4 Hungary Artificial Intelligence (AI) in Drug Discovery Market, By Offering |
6.4.1 Overview and Analysis |
6.4.2 Hungary Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume, By Software, 2021- 2031F |
6.4.3 Hungary Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume, By Services, 2021- 2031F |
6.5 Hungary Artificial Intelligence (AI) in Drug Discovery Market, By Indication |
6.5.1 Overview and Analysis |
6.5.2 Hungary Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume, By Immuno-Oncology, 2021- 2031F |
6.5.3 Hungary Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume, By Neurodegenerative Diseases, 2021- 2031F |
6.5.4 Hungary Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume, By Cardiovascular Diseases, 2021- 2031F |
6.5.5 Hungary Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume, By Metabolic Diseases, 2021- 2031F |
6.5.6 Hungary Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Hungary Artificial Intelligence (AI) in Drug Discovery Market, By End Use |
6.6.1 Overview and Analysis |
6.6.2 Hungary Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume, By Contract Research Organizations (CROs), 2021- 2031F |
6.6.3 Hungary Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume, By Pharmaceutical and Biotechnology Companies, 2021- 2031F |
6.6.4 Hungary Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume, By Research Centers and Academic Institutes, 2021- 2031F |
6.6.5 Hungary Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume, By Others, 2021- 2031F |
7 Hungary Artificial Intelligence (AI) in Drug Discovery Market Import-Export Trade Statistics |
7.1 Hungary Artificial Intelligence (AI) in Drug Discovery Market Export to Major Countries |
7.2 Hungary Artificial Intelligence (AI) in Drug Discovery Market Imports from Major Countries |
8 Hungary Artificial Intelligence (AI) in Drug Discovery Market Key Performance Indicators |
8.1 Adoption rate of AI technologies in drug discovery processes |
8.2 Time reduction in drug discovery timelines with the integration of AI |
8.3 Success rate of drug candidates identified using AI algorithms |
8.4 Number of collaborations between AI companies and pharmaceutical firms |
8.5 Increase in research publications utilizing AI in drug discovery |
9 Hungary Artificial Intelligence (AI) in Drug Discovery Market - Opportunity Assessment |
9.1 Hungary Artificial Intelligence (AI) in Drug Discovery Market Opportunity Assessment, By Application, 2021 & 2031F |
9.2 Hungary Artificial Intelligence (AI) in Drug Discovery Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.3 Hungary Artificial Intelligence (AI) in Drug Discovery Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.4 Hungary Artificial Intelligence (AI) in Drug Discovery Market Opportunity Assessment, By Offering, 2021 & 2031F |
9.5 Hungary Artificial Intelligence (AI) in Drug Discovery Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.6 Hungary Artificial Intelligence (AI) in Drug Discovery Market Opportunity Assessment, By End Use, 2021 & 2031F |
10 Hungary Artificial Intelligence (AI) in Drug Discovery Market - Competitive Landscape |
10.1 Hungary Artificial Intelligence (AI) in Drug Discovery Market Revenue Share, By Companies, 2024 |
10.2 Hungary Artificial Intelligence (AI) in Drug Discovery Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here